1. Home
  2. ARCC vs MDGL Comparison

ARCC vs MDGL Comparison

Compare ARCC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$19.15

Market Cap

13.6B

Sector

Finance

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$435.53

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCC
MDGL
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
10.0B
IPO Year
2004
2005

Fundamental Metrics

Financial Performance
Metric
ARCC
MDGL
Price
$19.15
$435.53
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
$22.11
$637.92
AVG Volume (30 Days)
8.4M
351.7K
Earning Date
05-04-2026
05-19-2026
Dividend Yield
10.13%
N/A
EPS Growth
N/A
41.32
EPS
1.86
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$6.65
$58.70
Revenue Next Year
$1.87
$46.88
P/E Ratio
$10.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.17
$265.00
52 Week High
$23.42
$615.00

Technical Indicators

Market Signals
Indicator
ARCC
MDGL
Relative Strength Index (RSI) 45.48 38.81
Support Level $18.78 $410.78
Resistance Level $20.28 $452.22
Average True Range (ATR) 0.50 20.37
MACD 0.01 -0.41
Stochastic Oscillator 53.66 23.85

Price Performance

Historical Comparison
ARCC
MDGL

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: